2,3,5-三甲基-6-(3-吡啶甲基)-1,4-苯醌（CV-6504）的合成与生物学评价，CV-6504是一种血栓素A2合酶和5-脂氧合酶的双重抑制剂，具有清除活性氧（AOS）的活性。 - Suppr

Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).

Terao S, Ohkawa S, Terashita Z, Shibouta Y, Nishikawa K

Chemistry Research Laboratories, Takeda Chemical Industries, Ltd, Osaka, Japan.

Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:173-6.

Abstract

摘要

Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:173-6.

J Med Chem. 1991 Jan;34(1):267-76. doi: 10.1021/jm00105a042.

Transplant Proc. 1994 Aug;26(4):2288-9.

J Med Chem. 1996 Aug 2;39(16):3148-57. doi: 10.1021/jm950725r.

J Med Chem. 1994 Sep 16;37(19):3062-70. doi: 10.1021/jm00045a011.

Clin Nephrol. 1986 Oct;26(4):195-202.

Chem Pharm Bull (Tokyo). 1991 Apr;39(4):917-21. doi: 10.1248/cpb.39.917.

Kidney Int. 1991 May;39(5):920-9. doi: 10.1038/ki.1991.115.

Eur J Pharmacol. 2008 Nov 19;598(1-3):123-31. doi: 10.1016/j.ejphar.2008.09.007. Epub 2008 Sep 22.

J Lipid Mediat. 1993 Mar-Apr;6(1-3):249-57.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。